Immunogenicity and reactogenicity after booster dose with AZD1222 via intradermal route among adult who had received CoronaVac
View ORCID ProfileRapisa Nantanee, View ORCID ProfilePuneyavee Aikphaibul, Peera Jaru-Ampornpan, Pimpayao Sodsai, Orawan Himananto, Tuangtip Theerawit, Jiratchaya Sophonphan, Punyot Tovichayathamrong, Kasama Manothummetha, Tysdi Laohasereekul, Narin Hiransuthikul, Nattiya Hirankarn, Thanyawee Puthanakit on behalf of the Study Team
doi: https://doi.org/10.1101/2021.12.12.21267695
Rapisa Nantanee
aCenter of Excellence in Pediatric Infectious Diseases and Vaccines, Chulalongkorn University, 1873, Rama IV Rd, Pathumwan, Bangkok, 10330, Thailand
bPediatric Allergy and Clinical Immunology Research Unit, Division of Allergy and Immunology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, The Thai Red Cross Society, 1873, Rama IV Rd, Pathumwan, Bangkok, 10330, Thailand
MDPuneyavee Aikphaibul
aCenter of Excellence in Pediatric Infectious Diseases and Vaccines, Chulalongkorn University, 1873, Rama IV Rd, Pathumwan, Bangkok, 10330, Thailand
cDivision of Pediatric Dermatology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, The Thai Red Cross Society, 1873, Rama IV Rd, Pathumwan, Bangkok, 10330, Thailand
MDPeera Jaru-Ampornpan
dVirology and Cell Technology Research Team, National Center for Genetic Engineering and Biotechnology (BIOTEC)
PhDPimpayao Sodsai
eCenter of Excellence in Immunology and Immune-mediated Diseases, Department of Microbiology, Faculty of Medicine, Chulalongkorn University, 1873, Rama IV Rd, Pathumwan, Bangkok, 10330, Thailand
PhDOrawan Himananto
fMonoclonal Antibody Production and Application Research Team, National Center for Genetic Engineering and Biotechnology (BIOTEC)
PhDTuangtip Theerawit
aCenter of Excellence in Pediatric Infectious Diseases and Vaccines, Chulalongkorn University, 1873, Rama IV Rd, Pathumwan, Bangkok, 10330, Thailand
RNJiratchaya Sophonphan
gThe HIV Netherlands Australia Thailand Research Collaboration (HIV-NAT), The Thai Red Cross AIDS Research Centre, Bangkok, Thailand
MScPunyot Tovichayathamrong
hDepartment of Microbiology, Faculty of Medicine, Chulalongkorn University, 1873, Rama IV Rd, Pathumwan, Bangkok, 10330, Thailand
MDKasama Manothummetha
hDepartment of Microbiology, Faculty of Medicine, Chulalongkorn University, 1873, Rama IV Rd, Pathumwan, Bangkok, 10330, Thailand
MDTysdi Laohasereekul
hDepartment of Microbiology, Faculty of Medicine, Chulalongkorn University, 1873, Rama IV Rd, Pathumwan, Bangkok, 10330, Thailand
MDNarin Hiransuthikul
iDepartment of Preventive and Social Medicine, Faculty of Medicine, Chulalongkorn University, 1873, Rama IV Rd, Pathumwan, Bangkok, 10330, Thailand
MD, PhDNattiya Hirankarn
eCenter of Excellence in Immunology and Immune-mediated Diseases, Department of Microbiology, Faculty of Medicine, Chulalongkorn University, 1873, Rama IV Rd, Pathumwan, Bangkok, 10330, Thailand
MD, PhDThanyawee Puthanakit
aCenter of Excellence in Pediatric Infectious Diseases and Vaccines, Chulalongkorn University, 1873, Rama IV Rd, Pathumwan, Bangkok, 10330, Thailand
MDData Availability
All data produced in the present study are available upon reasonable request to the authors.
Posted December 14, 2021.
Immunogenicity and reactogenicity after booster dose with AZD1222 via intradermal route among adult who had received CoronaVac
Rapisa Nantanee, Puneyavee Aikphaibul, Peera Jaru-Ampornpan, Pimpayao Sodsai, Orawan Himananto, Tuangtip Theerawit, Jiratchaya Sophonphan, Punyot Tovichayathamrong, Kasama Manothummetha, Tysdi Laohasereekul, Narin Hiransuthikul, Nattiya Hirankarn, Thanyawee Puthanakit
medRxiv 2021.12.12.21267695; doi: https://doi.org/10.1101/2021.12.12.21267695
Immunogenicity and reactogenicity after booster dose with AZD1222 via intradermal route among adult who had received CoronaVac
Rapisa Nantanee, Puneyavee Aikphaibul, Peera Jaru-Ampornpan, Pimpayao Sodsai, Orawan Himananto, Tuangtip Theerawit, Jiratchaya Sophonphan, Punyot Tovichayathamrong, Kasama Manothummetha, Tysdi Laohasereekul, Narin Hiransuthikul, Nattiya Hirankarn, Thanyawee Puthanakit
medRxiv 2021.12.12.21267695; doi: https://doi.org/10.1101/2021.12.12.21267695
Subject Area
Subject Areas
- Addiction Medicine (380)
- Allergy and Immunology (697)
- Anesthesia (187)
- Cardiovascular Medicine (2822)
- Dermatology (242)
- Emergency Medicine (426)
- Epidemiology (12516)
- Forensic Medicine (10)
- Gastroenterology (798)
- Genetic and Genomic Medicine (4395)
- Geriatric Medicine (399)
- Health Economics (711)
- Health Informatics (2829)
- Health Policy (1043)
- Hematology (372)
- HIV/AIDS (893)
- Medical Education (412)
- Medical Ethics (113)
- Nephrology (460)
- Neurology (4151)
- Nursing (220)
- Nutrition (614)
- Oncology (2186)
- Ophthalmology (622)
- Orthopedics (253)
- Otolaryngology (316)
- Pain Medicine (263)
- Palliative Medicine (81)
- Pathology (483)
- Pediatrics (1166)
- Primary Care Research (481)
- Public and Global Health (6733)
- Radiology and Imaging (1480)
- Respiratory Medicine (895)
- Rheumatology (429)
- Sports Medicine (361)
- Surgery (469)
- Toxicology (57)
- Transplantation (198)
- Urology (173)